BlackRock’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$366K Sell
599,487
-149,580
-20% -$91.2K ﹤0.01% 4447
2025
Q1
$566K Sell
749,067
-62,709
-8% -$47.3K ﹤0.01% 4321
2024
Q4
$781K Buy
811,776
+59,767
+8% +$57.5K ﹤0.01% 4234
2024
Q3
$1.08M Sell
752,009
-265,442
-26% -$382K ﹤0.01% 4106
2024
Q2
$1.23M Sell
1,017,451
-2,355,781
-70% -$2.85M ﹤0.01% 4070
2024
Q1
$7.93M Buy
3,373,232
+1,190,557
+55% +$2.8M ﹤0.01% 3411
2023
Q4
$4.13M Sell
2,182,675
-86,803
-4% -$164K ﹤0.01% 3688
2023
Q3
$3.11M Sell
2,269,478
-118,234
-5% -$162K ﹤0.01% 3793
2023
Q2
$5.8M Sell
2,387,712
-149,090
-6% -$362K ﹤0.01% 3588
2023
Q1
$14.6M Sell
2,536,802
-8,816
-0.3% -$50.8K ﹤0.01% 3057
2022
Q4
$22.8M Buy
2,545,618
+435,831
+21% +$3.9M ﹤0.01% 2904
2022
Q3
$30M Buy
2,109,787
+260,705
+14% +$3.71M ﹤0.01% 2764
2022
Q2
$27M Buy
1,849,082
+230,975
+14% +$3.37M ﹤0.01% 2861
2022
Q1
$32.3M Buy
1,618,107
+165,655
+11% +$3.31M ﹤0.01% 2807
2021
Q4
$25.4M Buy
1,452,452
+203,933
+16% +$3.57M ﹤0.01% 3081
2021
Q3
$9.79M Buy
1,248,519
+13,206
+1% +$104K ﹤0.01% 3624
2021
Q2
$12.7M Buy
1,235,313
+745,685
+152% +$7.67M ﹤0.01% 3495
2021
Q1
$6.4M Buy
489,628
+215,166
+78% +$2.81M ﹤0.01% 3767
2020
Q4
$3.86M Buy
274,462
+140,402
+105% +$1.97M ﹤0.01% 3733
2020
Q3
$1.59M Sell
134,060
-10,356
-7% -$123K ﹤0.01% 3866
2020
Q2
$2.17M Sell
144,416
-81,546
-36% -$1.23M ﹤0.01% 3726
2020
Q1
$1.63M Buy
225,962
+5,576
+3% +$40.2K ﹤0.01% 3647
2019
Q4
$2.3M Buy
220,386
+17,321
+9% +$181K ﹤0.01% 3690
2019
Q3
$12.6M Buy
203,065
+5,385
+3% +$333K ﹤0.01% 3069
2019
Q2
$14.1M Buy
197,680
+83,319
+73% +$5.95M ﹤0.01% 3011
2019
Q1
$5.46M Sell
114,361
-308
-0.3% -$14.7K ﹤0.01% 3344
2018
Q4
$6.92M Buy
114,669
+47,489
+71% +$2.87M ﹤0.01% 3256
2018
Q3
$7.12M Buy
67,180
+21,421
+47% +$2.27M ﹤0.01% 3348
2018
Q2
$2.93M Buy
45,759
+3,167
+7% +$203K ﹤0.01% 3578
2018
Q1
$2.86M Buy
+42,592
New +$2.86M ﹤0.01% 3542